Recruiting studies: Palsy Supranuclear

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT06645626 Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
NA · 1 location(s) · Peking University First Hospital · NCT07570212 Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144 Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809 ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Phase N/A · 27 location(s) · Mayo Clinic · NCT04363684 Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Phase N/A · 16 location(s) · Kliniken Beelitz GmbH · NCT04706234 Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
NA · 1 location(s) · Oregon Health and Science University · NCT04468932 Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT03872102 The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938 Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816 A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Phase 3 · 24 location(s) · Novartis Pharmaceuticals · NCT07498426 Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125 Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrati
Phase N/A · 4 location(s) · University Health Network, Toronto · NCT06529744 Synaptic Loss in Multiple System Atrophy
Phase N/A · 1 location(s) · University of Exeter · NCT05121012 The CurePSP Genetics Program
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06647641 UPenn Observational Research Repository on Neurodegenerative Disease
Phase N/A · 1 location(s) · University of Pennsylvania · NCT04715399 The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
NA · 1 location(s) · Queen Mary University of London · NCT06174948 tDCS as Treatment for Motor Function
NA · 1 location(s) · Baycrest · NCT07291687 The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Phase 2 · 3 location(s) · Haukeland University Hospital · NCT06162013 NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106 Diagnosing Frontotemporal Lobar Degeneration
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02964637 A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
NA · 1 location(s) · Mayo Clinic · NCT02605785 AI-Enhanced Optimization of Acute Levodopa Challenge Test
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06949865 Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844 Quality of Life of the Patient and the Burden of the Caregiver in Progressive Supranuclear Palsy
Phase N/A · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT03638505 Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Bioma
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT07392411 Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Phase N/A · 1 location(s) · Casa di Cura San Raffaele Cassino · NCT06596746 Neurologic Stem Cell Treatment Study
NA · 3 location(s) · MD Stem Cells · NCT02795052

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.